Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I-II Study of Stereotactic Body Radiation Therapy for Breast Cancer (SBRT Breast)

NCT03585621 is registered in ClinicalTrials.gov with Toronto Sunnybrook Regional Cancer Centre as lead sponsor.

NCT NCT03585621
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03585621 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I-II Study of Stereotactic Body Radiation Therapy for Breast Cancer (SBRT Breast)
Lead sponsor
Toronto Sunnybrook Regional Cancer Centre
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 17, 2018
Completion date
July 17, 2026
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer